Last $31.90 USD
Change Today -0.08 / -0.25%
Volume 372.6K
PODD On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 12:27 PM 03/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert S. Sherwin M.D.

Chairman of Scientific Advisory Board, Insulet Corporation
AgeTotal Calculated CompensationThis person is connected to 44 board members in 3 different organizations across 4 different industries.

See Board Relationships
----

Background*

Mr. Robert S. Sherwin, MD is the CNH Long Professor of Medicine, Section of Endocrinology at Yale University School of Medicine. Mr. Sherwin also serves as Director of the Diabetes Endocrinology Research Center and the General Clinical Research Center, Yale University, New Haven, Connecticut. He was subsequently appointed to the faculty of Yale University School of Medicine in 1974. Mr. Sherwin serves as Chairman & Member of the Scientific Advisory Board of Insulet Corporation. ...

Read Full Background

Corporate Headquarters*

9 Oak Park Drive
Bedford, Massachusetts 01730

United States

Phone: 781-457-5000
Fax: 781-457-5011

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Unknown/Other Education 1967
Albert Einstein College of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PODD:US $31.90 USD -0.08

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Vincent A. Forlenza BDChairman, Chief Executive Officer and President
Becton, Dickinson and Company
$985.0K
Kevin R. Sayer Chief Executive Officer, President and Director
DexCom, Inc.
$325.0K
Philip Bowman Chief Executive Officer and Executive Director
Smiths Group plc
1.5M GBP
Yasuchika Hasegawa Chairman and Chief Executive Officer
Takeda Pharmaceutical Company Limited
¥216.0M
Kim D. Blickenstaff Chief Executive Officer, President and Director
Tandem Diabetes Care, Inc.
$472.1K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INSULET CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.